PID00110 |
|
Gingerol |
125000 nM |
- |
Homo sapiens |
Cyclooxygenase-2 |
Bioorg. Med. Chem., (2008) 16:24:10332 |
- |
PID00110 |
|
Gingerol |
- |
- |
Homo sapiens |
Transient receptor potential cation channel subfamily V member 1 |
Bioorg Med Chem Lett 22: 1674-7 (2012) |
10400 |
PID00110 |
|
Gingerol |
5000 nM |
- |
Homo sapiens |
VEGF |
Kim E C, Min J K, Kim T Y, et al. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo[J]. Biochemical and biophysical research communications, 2005, 335(2): 300-308. |
- |
PID00110 |
|
Gingerol |
18300 nM |
- |
Homo sapiens |
TRPC5 |
- |
- |
PID00110 |
|
Gingerol |
160 µM |
- |
Homo sapiens |
PC-3 |
Mukkavilli, Rao, et al. Pharmacokinetic-pharmacodynamic correlations in the development of ginger extract as an anticancer agent.Scientific reports 8.1 (2018): 3056. |
- |
PID00110 |
|
Gingerol |
196 µM |
- |
Homo sapiens |
DU145 |
Mukkavilli, Rao, et al. "Pharmacokinetic-pharmacodynamic correlations in the development of ginger extract as an anticancer agent." Scientific reports 8.1 (2018): 3056. |
- |
PID00110 |
|
Gingerol |
12.1 µM |
- |
Homo sapiens |
- |
Li, Mian, et al. Pungent ginger components modulates human cytochrome P450 enzymes in vitro. Acta Pharmacologica Sinica 34.9 (2013): 1237. |
- |
PID00110 |
|
Gingerol |
30.7 µM |
- |
Homo sapiens |
CYP2C19 |
Li, Mian, et al. Pungent ginger components modulates human cytochrome P450 enzymes in vitro. Acta Pharmacologica Sinica 34.9 (2013): 1237. |
- |
PID00110 |
|
Gingerol |
26.3 µM |
- |
Homo sapiens |
PGE2 |
Dugasani, Swarnalatha, et al. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol,[8]-gingerol,[10]-gingerol and [6]-shogaol.Journal of ethnopharmacology 127.2 (2010): 515-520. |
DPPH radical |
PID00110 |
|
Gingerol |
4.05 µM |
- |
Homo sapiens |
PGE2 |
Dugasani, Swarnalatha, et al. Comparative antioxidant and anti-inflammatory effects of [6]-gingerol,[8]-gingerol,[10]-gingerol and [6]-shogaol. Journal of ethnopharmacology 127.2 (2010): 515-520. |
superoxide radical |